Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Rewiring the Chronic Pain Experience: Single-Session Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital

30. oktober 2026 oppdatert av: Ottawa Hospital Research Institute

Rewiring the Chronic Pain Experience: Feasibility and Pilot Testing of a Single-Session, 4-Hour Delivery Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital (TOH)

The goal of this study is to find out if a one-time session of Pain Reprocessing Therapy (PRT) intervention improves participant's mood and pain. Participants in this 4 hours session will be 40 patients who've been referred to the The Ottawa Hospital Pain Clinic (TOHPC) for chronic pain.

The main questions of this study are:

  • Can we recruit 40 participants within 6 months?
  • Do at least 32 participants complete the session and answer follow up questions?
  • Does 1 session of PRT have a positive impact on participants' mood and pain?

Participants in this study will:

  • Attend 1 session of PRT.
  • Answer questions that relate to their experience of pain and their mood. They will answer these questions immediately before/after the session, 1 week after the session, and 1 month after the session.
  • After the session, some participants will participate in an interview to talk about their experience.

Studieoversikt

Status

Rekruttering

Forhold

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Susan Ward, MSW
  • Telefonnummer: 72123 613-737-8899
  • E-post: SWard@toh.ca

Studer Kontakt Backup

Studiesteder

    • Ontario
      • Ottawa, Ontario, Canada, K1H8L6
        • Rekruttering
        • The Ottawa Hospital
        • Hovedetterforsker:
          • Susan Ward, MSW

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Minimum age of 18 years or older at time of consent.

  • Chronic pain persisting for a minimum of 3 months, consistent with the International Association for the Study of Pain (IASP) definition of chronic pain.

  • Self-reported 1-week average pain intensity score between 4/10 and 9/10 on the Brief Pain Inventory (BPI)12 at screening.

    o Note: Individuals scoring less than 4/10 or more than 9/10 will be directed to other pain clinic workshops and available resources (e.g., Power Over Pain)

  • Referred to TOHPC and triaged by a registered nurse, nurse practitioner, or physician to the "diffuse pain" pathway;

  • Completed the initial pain clinic patient education and resource session (PERS) for patients triaged to the "diffuse pain" pathway;

  • Currently waiting for a 1st consultation with the Nurse Practitioner assigned to the "diffuse pain" pathway.

  • Able to read, write, and communicate in English at a level sufficient to engage with research team, the psychoeducational content, and to complete self-report measures.

  • Able to attend a single, in-person 4-hour group session at TOHPC in Ottawa on a scheduled weekday.

Exclusion Criteria:

  • Active mental health symptoms that significantly interfere with the ability to engage with psychoeducational content (e.g., dissociation, active psychosis), or participate in a group setting
  • Cognitive impairment that significantly limits the ability to comprehend study information, provide informed consent, or meaningfully engage with psychoeducational content.
  • Scheduled for a major surgical procedure within the study timeframe.
  • Currently receiving other individual or group psychotherapy that directly targets pain, pain cognitions, or pain-related emotional responses within the 12 weeks prior to enrollment.
  • Currently receiving interventional pain management services (e.g., injections, nerve blocks) from another clinic or institution within the 12-week period prior to enrollment through the 3-month follow-up.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Pain Reprocessing Therapy (PRT) session

The intervention involves a single 4-hour PRT in-person group session (up to 20 patients per group) at The Ottawa Hospital Pain Clinic, delivered by a PRT certified clinician.

The intervention is a brief mindfulness exercise (mindfulness of breath, energy, emotions, thoughts, sensations), followed by 90 minutes of didactic content focused on pain science education and foundation of pain reprocessing therapy. This includes interactive discussions, self-reflection, and skills building. This is followed by a brief exercise called predictive coding where participants are invited to draw a picture representing their pain. The remainder of the session includes gentle movement, somatic tracking, and practices to increase positive affect induction- specifically leaning into positive or neutral sensations and establishing short-term safety behaviours.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Clinical Effectiveness: Brief Pain Inventory (BPI) Pain Intensity and Pain Interference
Tidsramme: Baseline, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Brief Pain Inventory (BPI): Participants will localize their pain through a drop down menu, in which they will select the applicable body part(s) where they experience pain. The BPI Pain Intensity and Pain Interference scales will then be administered. The pain intensity subscale includes 4 pain intensity ratings using an 11-point numerical rating scale (0-10) on current pain, average pain, worst pain during the last 7 days and least pain during the last 24 hours. The pain interference subscale includes 7 interference items that ask the patient to respond using an 11-point numerical rating scale (0-10). These items include the effect on general activity, mood, walking ability, normal work (including housework), relations with other people, sleep, and enjoyment of life.

Baseline, 1 week post-intervention, 1 month follow up.
Interview
Tidsramme: Interviews will be conducted within 6 months of participating in the PRT session.

A random selection of participants will be interviewed regarding their PRT experience.

Interviews will be conducted within 6 months of participating in the PRT session.
Clinical Effectiveness: Pain Self-Efficacy Questionnaire (PSEQ-10)
Tidsramme: Baseline, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Pain Self-Efficacy Questionnaire (PSEQ-10): The PSEQ-10 is a validated 10-item tool for assessing the patient's pain self-efficacy or belief in one's capability to perform activities even when undergoing pain. The 10 items ask the patient to rate their confidence in doing activities on a 7-point numerical rating scale (0-6), with higher scores indicating greater confidence.

Baseline, 1 week post-intervention, 1 month follow up.
Clinical Effectiveness: Patients' Global Impression of Change (PGI-C) Scale
Tidsramme: 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Patients' Global Impression of Change (PGI-C) Scale: The PGI-C is a validated single- item self-report measure used to assess a patient's perceived change in overall status following a treatment or intervention. Patients select one of 7 options to describe their experience, ranging from "very much worse" to "very much improved." The PGI-C is widely used in chronic pain research and has demonstrated sensitivity to clinically meaningful change across a range of pain populations.

1 week post-intervention, 1 month follow up.
Clinical Effectiveness: Positive and Negative Affect Scale (PANAS)
Tidsramme: Day of Intervention, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Positive and Negative Affect Scale (PANAS) PANAS is a validated 20-item self-report measure assessing two distinct dimensions of mood: positive affect and negative affect. Participants rate the extent to which they have experienced each emotion using a 5-point Likert scale (1 = very slightly or not at all, 5 = extremely), with higher positive affect scores and lower negative affect scores reflecting better emotional well-being. The PANAS has demonstrated strong reliability and validity across clinical populations, including individuals with chronic pain.

Day of Intervention, 1 week post-intervention, 1 month follow up.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Feasibility of recruitment
Tidsramme: Baseline

• Rates of participant eligibility and consenting will be tracked

o The single session PRT model will be considered feasible if we can recruit our target sample size of 40 participants over a 6-month period.

Baseline
Rate of participant accrual/completion
Tidsramme: Baseline, Day 7, and Day 30

• Rates of participant accrual, screening, and 1-week and 1-month assessment completion will be tracked

o The evaluation procedures will be considered feasible if we retain more than 80% of participants at 1-month follow-up.

Baseline, Day 7, and Day 30

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Susan Ward, MSW, The Ottawa Hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

16. oktober 2026

Primær fullføring (Antatt)

1. mai 2027

Studiet fullført (Antatt)

1. oktober 2027

Datoer for studieregistrering

Først innsendt

14. oktober 2026

Først innsendt som oppfylte QC-kriteriene

30. oktober 2026

Først lagt ut (Faktiske)

5. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere